Suppr超能文献

制定毛细血管畸形临床研究的核心结局领域集(COSCAM 项目)。

Development of a core outcome domain set for clinical research on capillary malformations (the COSCAM project).

机构信息

Department of Surgery, Amsterdam University Medical Center (UMC) Location AMC, University of Amsterdam, Amsterdam, The Netherlands.

Department of Dermatology, Amsterdam University Medical Center UMC, Amsterdam Public Health, Immunity and Infections, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

J Eur Acad Dermatol Venereol. 2021 Sep;35(9):1888-1895. doi: 10.1111/jdv.17376. Epub 2021 Jun 16.

Abstract

BACKGROUND

Due to a large variety in treatment outcomes reported in therapeutic trials and lacking patient-relevant outcomes, it is hard to adequately compare and improve current therapies for patients with capillary malformations (CMs). The Core Outcome Set for Capillary Malformations (COSCAM) project aims to develop a core outcome set (COS) for use in future CM trials, in which we will first develop a core outcome (sub)domain set (CDS). Here, we describe the methods for the development of a CDS and present the results of the first development stage.

METHODS

The COSCAM project is carried out according to the recommendations of the Cochrane Skin Core OUtcomes Set INitiative (CS-COUSIN) and the Core Outcome Measures in Effectiveness Trials (COMET) initiative. During the first stage, we identified all potentially relevant outcome subdomains based on a systematic review, two focus group sessions and input from patient representatives of Dutch patient organizations and the COSCAM-founding group. In stage two, we will present the subdomains in a three-round e-Delphi study and online consensus meeting, in which CM patients, parents/caregivers and CM experts worldwide rate the importance of the proposed subdomains, hereby finalizing the core outcome (sub)domains of the CDS.

RESULTS

A total of 67 potential outcome subdomains were included; sixteen were previously used in the literature, 20 were proposed by Dutch patients and their parents/caregivers (n = 13) in focus group sessions and 38 were suggested by the experts of the COSCAM-founding group. Seven were excluded because of overlap.

CONCLUSION

The final CDS may serve as a minimum standard in future CM trials, thereby facilitating adequate comparison of treatment outcomes. After this CDS development, we will select appropriate outcome measurement instruments to measure the core outcome subdomains.

摘要

背景

由于治疗试验报告的治疗结果差异很大,且缺乏与患者相关的结果,因此难以充分比较和改进目前针对毛细血管畸形(CM)患者的治疗方法。毛细血管畸形核心结局集(COSCAM)项目旨在为未来的 CM 试验制定核心结局集(COS),我们将首先制定核心结局(子)领域集(CDS)。在这里,我们描述了制定 CDS 的方法,并介绍了第一开发阶段的结果。

方法

COSCAM 项目是根据 Cochrane 皮肤核心结局集倡议(CS-COUSIN)和有效性试验核心结局测量工具(COMET)倡议的建议开展的。在第一阶段,我们根据系统评价、两次焦点小组会议以及来自荷兰患者组织和 COSCAM 创始小组的患者代表的意见,确定了所有潜在的相关结局子领域。在第二阶段,我们将在三轮电子德尔菲研究和在线共识会议中提出子领域,CM 患者、父母/照顾者和全球 CM 专家将对拟议的子领域的重要性进行评分,从而最终确定 CDS 的核心结局(子)领域。

结果

共纳入 67 个潜在的结局子领域;其中 16 个以前在文献中使用过,20 个是荷兰患者及其父母/照顾者在焦点小组会议中提出的(n=13),38 个是由 COSCAM 创始小组成员的专家提出的。由于重叠,有 7 个子领域被排除在外。

结论

最终的 CDS 可作为未来 CM 试验的最低标准,从而促进治疗结果的充分比较。在这个 CDS 开发之后,我们将选择适当的测量工具来测量核心结局子领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf37/8453952/a02a96a03bc6/JDV-35-1888-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验